Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The present lack of effective therapies for osteoarthritis, the most diffused musculoskeletal disease, correlates with the absence of representative in vitro disease models. Microfabrication techniques and soft lithography allow the development of organs and tissues on chip with increased mimicry of human pathophysiology. Exploitation of polydimethylsiloxane elasticity, furthermore, permits to incorporate finely controlled mechanical actuators which are of the utmost importance in a faithful representation of the intrinsically active environment of musculoskeletal districts, to increase our comprehension of the disease onset and to successfully predict the response to pharmacological therapies. Here, we portray the fabrication and operational processes for the development of a cartilage-on-a-chip model. Additionally, we describe the methodologies to induce a phenotype reminiscent of osteoarthritis solely through hyperphysiological cyclic compression. The techniques to assess achievement of such features through immunofluorescence and gene expression are also detailed.

More information Original publication

DOI

10.1007/978-1-0716-1693-2_14

Type

Journal article

Publication Date

2022-01-01T00:00:00+00:00

Volume

2373

Pages

231 - 251

Total pages

20

Keywords

Cartilage-on-a-chip, Disease Modeling, Mechanical stimulation, Osteoarthritis, Cartilage, Cartilage, Articular, Humans, Lab-On-A-Chip Devices, Oligonucleotide Array Sequence Analysis, Osteoarthritis, Phenotype, Stress, Mechanical